Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07048314 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Stem Cells for Erectile Dysfunction Post RALP

StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Mar 10, 2026 to Jul 7, 2026 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Mar 10, 2026 to Jul 7, 2026
    • Site details revised
  2. Start date: Jul 1, 2025 to Mar 10, 2026v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a phase 1/2 single center, pilot study to assess safety and efficacy of allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) and to evaluate the timing and combination effects of active treatment versus placebo in promoting the recovery of erectile function in patients undergoing radical retropubic prostatectomy (RALP) of localized prostate cancer.
Trial Details
NCT Number NCT07048314
Lead Sponsor The Methodist Hospital Research Institute
Conditions Erectile Dysfunction, Prostate Cancer
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov